Literature DB >> 3590615

Porcine effector mechanisms: antibody-dependent cell-mediated cytotoxicity of pseudorabies-infected target cells.

M Kensinger, M L Eskew, W Scheuchenzuber, A Zarkower.   

Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) against pseudorabies virus (PRV)-infected cells was determined in neonatal porcine pulmonary washout cells and in partially purified blood-derived leukocytes. The ADCC assays were performed at approximately 1, 2, 3 and 11 days after birth. It was found that pulmonary-derived cells had a low level of cytolytic activity against the PRV-infected target cells at about 1 day of age. This activity increased sharply during the next 2 days of age, but declined somewhat by 11 days of age. The increase in ADCC activity paralleled closely the increase in the relative and absolute numbers of macrophages in the alveolar washout fluids. ADCC activity was high at all times in blood-derived neutrophils, and present in blood-derived lymphocytes, but at a lower level of activity.

Entities:  

Mesh:

Year:  1987        PMID: 3590615     DOI: 10.1016/0165-2427(87)90091-2

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  3 in total

1.  Activated porcine alveolar macrophages: are biological response modifiers the answer?

Authors:  S K Chapes; C G Chitko; R C Thaler; J L Nelssen; G A Anderson; F Blecha
Journal:  Vet Immunol Immunopathol       Date:  1989-08       Impact factor: 2.046

2.  Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.

Authors:  M Riviere; J Tartaglia; M E Perkus; E K Norton; C M Bongermino; F Lacoste; C Duret; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Effects of pseudorabies virus infection upon cytotoxicity and antiviral activities of porcine alveolar macrophages.

Authors:  G Iglesias; C Pijoan; T Molitor
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1992-10       Impact factor: 2.268

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.